Evidence map›Paper›PMID 37779072›Full record

ArticleInternal medicine (Tokyo, Japan)2023

An Autopsy Case of Post-COVID-19 Interstitial Lung Disease with Acute Exacerbation.

Akifumi Tsuzuku, Fumihiro Asano, Masaki Katayama, Kosuke Mori, Yui Sasaki, Yutaro Kuzunishi, Mayuka Taguchi, Yuya Muto, Yasutomo Baba, Akimasa Tsuchida and 5 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Akifumi TsuzukuDepartment of Pulmonary Medicine, Gifu Prefectural General Medical Center, Japan.
Fumihiro AsanoDepartment of Pulmonary Medicine, Gifu Prefectural General Medical Center, Japan.
Masaki KatayamaDepartment of Pathology, Gifu Prefectural General Medical Center, Japan.
Kosuke MoriDepartment of Pathology, Gifu University Hospital, Japan.
Yui SasakiDepartment of Pulmonary Medicine, Gifu Prefectural General Medical Center, Japan.
Yutaro KuzunishiDepartment of Pulmonary Medicine, Gifu Prefectural General Medical Center, Japan.
Mayuka TaguchiDepartment of Pulmonary Medicine, Gifu Prefectural General Medical Center, Japan.
Yuya MutoDepartment of Pulmonary Medicine, Gifu Prefectural General Medical Center, Japan.
Yasutomo BabaDepartment of Pulmonary Medicine, Gifu Prefectural General Medical Center, Japan.
Akimasa TsuchidaDepartment of Pulmonary Medicine, Gifu Prefectural General Medical Center, Japan.
Tomoya KatoDepartment of Pulmonary Medicine, Gifu Prefectural General Medical Center, Japan.
Anri MurakamiDepartment of Pulmonary Medicine, Gifu Prefectural General Medical Center, Japan.
Atsunori MasudaDepartment of Pulmonary Medicine, Gifu Prefectural General Medical Center, Japan.
Takashi YoshizaneDepartment of Cardiology, Gifu Prefectural General Medical Center, Japan.
Jun SuzukiDepartment of Infectious Disease, Gifu Prefectural General Medical Center, Japan.
Gifu Prefectural General Medical Center · JPGifu University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prognosis of patients with post-coronavirus disease 2019 (COVID-19) interstitial lung disease remains unclear. We herein report an autopsy case in which serial progression after the onset of post-COVID-19 interstitial lung disease resulted in an acute exacerbation, leading to a fatal outcome. Autopsy findings included hyaline membrane formation/interstitial inflammatory cell infiltration, suggestive of acute lesions, and severe regional fibrosis, indicating a preexisting chronic condition. In the present case, we histopathologically confirmed the acute exacerbation of post-COVID-19 interstitial lung disease.

Indexed as

COVID-19Lung Diseases, InterstitialAutopsyHumansautopsy pathologydiffuse alveolar damageinterstitial lung diseasepost-COVID-19

Identifiers

PMID37779072
PMCPMC10749816
OpenAlexW4387123578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.